Biotech Fund Doubles Down: Scholar Rock Bet Drives 26% Rally
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Uncover Ways To Visualize Financial Goal Progress with charts and visuals that make progress tangible, boosting motivation and consistency.
21,483 articlesA major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Traders eye a clearer long-run path for algorand as the network scales DeFi apps and CBDC pilots. This report outline...
A high dividend can spark doubt. This article breaks down pfizer's 6.5% dividend yield, what it signals about the bus...
Snowflake beat estimates, raised its full-year outlook, and committed $6 billion to expand collaboration with AWS, se...
A viral AI-generated forecast circulating online claims XRP could surge by 2030 under a three-scenario framework. Ana...
A wave of quantum funding is moving beyond labs to big-name backers. BlackRock, Nvidia, and Temasek are leading a sur...
A CEO’s share sale at Mineralys shines a light on insider moves ahead of a key FDA event. This guide breaks down what...
Today’s morning minute: supreme court news could move crypto prices and policy bets. We break down what happened, why...
Investors eye Hewlett Packard Enterprise’s 2026 earnings call for guidance on AI demand, GreenLake growth, and capita...
As investors eye small-cap medical devices, Inogen's INGN 2026 earnings story matters. This analysis breaks down Q1 r...
Natera shows growth through AI-enabled cell-free DNA tests and a widening data moat, positioning it as a leading nate...
Tuesday brought a notable standout in the banking space as JPMorgan Chase topped market momentum. This piece breaks d...